11 completed, 2 not yet recruiting, 2 recruiting, 2 unknown. 10 Phase 1, 6 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 7, Unknown 2, Recruiting 1 |
| Phase 2 | 6 | Completed 3, Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow Hemay005: new trials by email Literature Review of Hemay005 trials Research Report on Hemay005
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis Hemay005 tablet, Placebo - Ulcerative Colitis (UC) | Phase 3 | Not yet recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 360 | 2026-06-01 | 2026-06-16 |
| A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD Hemay005 tablets, Roflumilast Oral Tablet, Placebo tablet - COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Not yet recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 120 | 2026-01-01 | 2026-01-02 |
| Evaluation the Safety of hemay005 Tablets Hemay005 tablet, Placebo - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Anhui Hemay Pharmaceutical Co., Ltd | 468 | 2024-12-25 | 2025-12-09 |
| Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets Hemay005, Midazolam maleate - Psoriasis | Phase 1 | Completed | Ganzhou Hemay Pharmaceutical Co., Ltd | 20 | 2024-12-12 | 2025-12-03 |
| Bioequivalence Test of Hemay005 Tablets Hemay005 - Psoriasis | Phase 1 | Completed | Ganzhou Hemay Pharmaceutical Co., Ltd | 28 | 2024-09-15 | 2025-03-18 |
| To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment Hemay005 - Psoriasis | Phase 1 | Completed | Ganzhou Hemay Pharmaceutical Co., Ltd | 26 | 2024-05-07 | 2025-12-04 |
| To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage Hemay005 - Psoriasis | Phase 1 | Recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 24 | 2024-04-28 | 2025-12-04 |
| A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease Hemay005, Placebo - Behçet's Disease | Phase 3 | Recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 162 | 2023-11-13 | 2025-04-08 |
| A Study to Evaluate the Effects of Single and Multiple Doses of Hemay005 Tablets in Health Caucasian Adult Volunteers Hemay005 60 mg - Healthy | Phase 1 | Completed | Ganzhou Hemay Pharmaceutical Co., Ltd | 12 | 2023-07-17 | 2024-03-01 |
| A Study of Hemay005 in Adult With Atopic Dermatitis Hemay005 - Hemay005, Atopic Dermatitis | Phase 2 | Completed | Ganzhou Hemay Pharmaceutical Co., Ltd | 79 | 2022-11-24 | 2024-03-01 |
| Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis Hemay005 tablets, Hemay005 placebo tablets - Moderate to Severe Ulcerative Colitis | Phase 2 | Active not recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 92 | 2022-11-08 | 2026-04-03 |
| Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis Hemay005 - Active Ankylosing Spondylitis | Phase 2 | Completed | Tianjin Hemay Pharmaceutical Co., Ltd | 90 | 2022-08-05 | 2024-01-11 |
| A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis 60mg Hemay005, Placebo - Psoriasis | Phase 3 | Completed | Tianjin Hemay Pharmaceutical Co., Ltd | 306 | 2022-01-20 | 2024-01-16 |
| Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects Hemay005 - Psoriasis | Phase 1 | Completed | Tianjin Hemay Pharmaceutical Co., Ltd | 12 | 2021-04-29 | 2024-03-06 |
| A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease Hemay005, Placebo - Behçet Disease | Phase 2 | Terminated | Tianjin Hemay Pharmaceutical Co., Ltd | 89 | 2020-11-30 | 2022-06-21 |
| Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis 15mg Hemay005, Placebos - Psoriasis | Phase 2 | Completed | Tianjin Hemay Pharmaceutical Co., Ltd | 216 | 2019-05-30 | 2021-10-13 |
| A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers Hemay005 - Psoriasis | Phase 1 | Unknown | Tianjin Hemay Bio-Tech Co., Ltd | 12 | 2018-10-10 | 2018-07-05 |
| Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects Hemay005, Placebo - Psoriasis | Phase 1 | Unknown | Tianjin Hemay Bio-Tech Co., Ltd | 24 | 2018-07-10 | 2018-10-02 |
| Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects Hemay005, Placebos - Psoriasis | Phase 1 | Completed | Tianjin Hemay Bio-Tech Co., Ltd | 68 | 2016-12-01 | 2018-06-19 |
Psoriasis (10) · Behcet Syndrome (2) · Pulmonary Disease, Chronic Obstructive (2) · Colitis, Ulcerative (1) · Dermatitis, Atopic (1) · Inflammatory Bowel Diseases (1)
Ganzhou Hemay Pharmaceutical Co., Ltd (10) · Tianjin Hemay Pharmaceutical Co., Ltd (5) · Tianjin Hemay Bio-Tech Co., Ltd (3) · Anhui Hemay Pharmaceutical Co., Ltd (1)
China (17) · Australia (1)
Hongyun Wang, Doctor (2) · Weiyong Li (2) · Christopher J Argent (1) · Min Zheng, Dr (1) · Minhu Chen, M.D (1) · Shutian Zhang, MD (1) · Xiaofeng Zeng, M.D (1) · Zhanguo Li, Doctor (1)